CME Presentations
Oncology Diagnostics
Presentations
Implementing Patient‐centered Early Cancer Detection Practices
Speakers: Lincoln Nadauld, MD, PhD, Executive Director, Precision Medicine and Precision GenomicsGregory Plotnikoff, MD, MTS, FACP, Internal Medicine Specialist Duration: 60 minutes
Presented on: April 13, 2022
Speakers
CME Information
Implementing Patient‐centered Early Cancer Detection Practices
ACKNOWLEDGEMENT
Supported by independent educational grants from GRAIL Inc.TUITION
Complimentary
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.LIVE CREDIT DESIGNATION STATEMENT
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.ENDURING CREDIT DESIGNATION STATEMENT
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.DATE OF RELEASE/EXPIRATION
Live Activity
Wednesday, April 13, 2022, at 11:00 am - 12:00 pm ESTEnduring Material
April 13, 2022 - April 13, 2023LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:- Distinguish between current MCED tests, trial designs, and clinical data
- Evaluate practical considerations and new workflows to improve integration of new screening approaches
- Promote patient-centered multi-screening practices through better understanding of real-world patient perspectives and experiences
TARGET AUDIENCE
The intended audience for this activity program are primary care physicians, internists, family physicians, nurses, physician assistants, nurse practitioners in primary care practices, oncologists, and hematologists.ESTIMATED TIME TO COMPLETE
This activity should take approximately 1 hour to complete.METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.OMedLive.com and www.ClinicalSeriesLive.com.To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:Name of Faculty or Presenter Reported Financial Relationship Gregory A. Plotnikoff, MD, MTS, FACP
Minnesota Personalized Medicine
Minneapolis, MNSpeakers Bureau/Honoraria for non-CME: GRAIL Inc.
Constultant/Advisory Board: DiaSorinLincoln Nadauld, MD, PhD
Vice President, Chief of Precision Health and Academics Intermountain Healthcare
Salt Lake City, UtahEmployee/Owner: Clarified Precision Medicine
Consultant/Advisory Board: Ciitizen Corporation
Non-Mutual Funds Stock Ownership/Stock Options: Culmination Bio
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner Reported Financial Relationship Tariqa Ackbarali
Medical Director
PlatformQ Health Education, LLCNone
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Jaimee Harris-Gold, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.CONTACT INFORMATION
Accreditation Support:
Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.Technical Support:
For any technical issues or issues with your CME Certificate, please contact ClinicalSeriesLive.com at 877-394-1306 or at Support@ClinicalSeriesLive.com.Taking Steps Toward Achieving Cancer Control: Is Multi-Cancer Screening the Solution?
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:- Review the need for early screening and detection of various cancer types and its impact on improving patient survival
- Evaluate emerging multi-cancer screening tests and their scope in potentially transforming cancer care
- Assess clinical protocols for transitioning care in a timely and appropriate manner
- Facilitate shared decision-making with patients based on screening results
Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLCACKNOWLEDGEMENT
This activity is supported by an educational grant from GRAIL Inc.TUITION
Complimentary
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.CREDIT DESIGNATION STATEMENTS
Live Activity
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Enduring Material
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.DATE OF RELEASE/EXPIRATION
Live Activity
September 22, 2020 from 12:00-1:00pm ET.Enduring Material
The enduring material will be available from September 22, 2020 – September 22, 2021.TARGET AUDIENCE
This activity is intended for primary care physicians, NPs in primary care practice, and oncologists.ESTIMATED TIME TO COMPLETE
This activity consists of 1 session which should take approximately 1 hour to complete.METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to www.OMedLive.com or www.ClinicalSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:Name of Faculty or Presenter Reported Financial Relationship Minetta C. Liu, MD
Professor and Research Chair, Department of Oncology,
Mayo ClinicContracted Research: Eisai, Genentech, GRAIL, Menarini Silicon Biosystems, Merck, Novartis, Seattle Genetics, Tesaro (all funds given to institution; no personal compensation) Catherine Marinac, PhD
Member of Faculty, Division of Population Sciences,
Dana-Farber Cancer InstituteNone
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter Reported Financial Relationship Tariqa Ackbarali
Medical Director
PlatformQ Health Education, LLCNone
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.CONTACT INFORMATION
Accreditation Support: Please contact the Postgraduate Institute for Medicine at www.pimed.com.
Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.